| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT05430802 Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIA-IIIB… |
Enrollment closed, study ongoing |
| 2026-08-12 | NCT05430802 Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIA-IIIB… |
date change Completion pushed: 2026-09-01 -> 2029-12-01 |
| 2026-08-09 | NCT06503042 A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy… |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-09 | NCT06485557 A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment… |
overall status: Not Yet Recruiting → Unknown |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-07 | NCT07752394 Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal… | Phase 2 | Not Yet Recruiting |
| 2026-07-23 | NCT07721441 Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence… | Enrolling by Invitation |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06467786 | Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer | Small Cell Lung Cancer | Recruiting |
| NCT07699770 | Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled… | Neuromyelitis Optica Spectrum Disorders (NMOSD) | Not Yet Recruiting |
| Phase 3 | |||
| NCT07141303 | Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior… | Acute Ischemic Stroke | Recruiting |
| NCT06952621 | Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus… | Esophageal Squamous Cell Carcinoma (ESCC) | Not Yet Recruiting |
| Phase 2 | |||
| NCT06006650 | Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell | Neoadjuvent | Recruiting |
| NCT06055738 | Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant… | Locally Advanced Cervical Cancer | Recruiting |
| NCT06475209 | Adebrelimab + Apatinib in SCLC Maintenance Therapy | SCLC | Recruiting |
| NCT06485544 | Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial | Small Cell Lung Cancer (SCLC) | Recruiting |
| NCT06663059 | Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study | Esophageal Cancer | Recruiting |
| NCT05067348 | Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis | Myasthenia Gravis, Generalized | Recruiting |
| NCT06864624 | Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC | NSCLC | Recruiting |
| NCT07141264 | Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy | SCLC,Extensive Stage | Recruiting |
| NCT07353723 | Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar… | Head & Neck Cancer | Recruiting |
| NCT07516522 | Intra-arterial Methylprednisolone After Endovascular Thrombectomy | Ischemia Stroke | Recruiting |
| NCT06065046 | Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions | Traumatic Brain Injury | Recruiting |
| NCT07596121 | Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50% | NSCLC (Non-small Cell Lung Cancer) | Recruiting |
| NCT07452601 | Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT06439615 | Baricitinib for the Lung Injury Following Spontaneous SAH | Spontaneous Subarachnoid Hemorrhage | Not Yet Recruiting |
| NCT06475755 | Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet… | Non-Small Cell Lung Cancer | Not Yet Recruiting |
| NCT05400070 | Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in… | Sintilimab | Active, Not Recruiting |
| NCT06851169 | This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart… | Non Small Cell Lung Cancer | Not Yet Recruiting |
| NCT06978153 | This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart… | Limited Stage Small Cell Lung Cancer | Not Yet Recruiting |
| NCT07618910 | Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC | Esophageal Squamous Cell Carcinoma | Not Yet Recruiting |
| NCT07618923 | Neoadjuvant Dalpiciclib + AI → SHR-A1811 for HR+/HER2-Low Breast Cancer | Breast Cancer | Not Yet Recruiting |
| NCT07678580 | Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally… | Esophageal Squamous Cell Carcinoma (ESCC) | Not Yet Recruiting |